Hemington Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Hemington Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1K	Buy	+85	New	+$1.26K	﹤0.01%	1490

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hemington Wealth Management's TAK Position: Q3 2025 in Review

Hemington Wealth Management opened a new position in Takeda Pharmaceutical (TAK) in Q3 2025: 85 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings.

329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

Hemington Wealth Management held 85 shares of Takeda Pharmaceutical worth $1K as of Q3 2025.
Takeda Pharmaceutical was a new Hemington Wealth Management position in Q3 2025.
Takeda Pharmaceutical made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1490 holding.
329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.